Quick Answer
CLOVER HEALTH INVESTMENTS, CORP. /DE reported Cash and Equivalents of $78.30 million for fiscal year 2025.
CLOVER HEALTH INVESTMENTS, CORP. /DE Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $78.30M | -59.8% |
| 2024 | $194.54M | +58.3% |
| 2023 | $122.86M | +18.4% |
| 2022 | $103.79M | -65.4% |
| 2021 | $299.97M | +224.8% |
| 2020 | $92.35M | — |
| 2019 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $287.96M | -3.7% | +13.0% |
| June 30, 2024 | $254.77M | -17.8% | +22.3% |
| March 31, 2024 | $208.25M | +9.3% | +78.9% |
| December 31, 2023 | $116.41M | +12.2% | -61.1% |
| September 30, 2023 | $299.01M | -21.9% | -3.6% |
| June 30, 2023 | $310.08M | -4.4% | +62.7% |
| March 31, 2023 | $190.56M | -30.4% | +83.6% |
| December 31, 2022 | $103.79M | -65.4% | -72.9% |
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed a decrease of -59.8% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from CLOVER HEALTH INVESTMENTS, CORP. /DE’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: